Market Capitalization (Millions $) |
81 |
Shares
Outstanding (Millions) |
7 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-197 |
Cash Flow (TTM) (Millions $) |
-31 |
Capital Exp. (TTM) (Millions $) |
34 |
Instil Bio Inc
Instil Bio Inc is a biotechnology company that focuses on developing innovative cell and gene therapies for the treatment of cancer. The company is committed to utilizing cutting-edge technologies to engineer and modify immune cells to enhance their ability to recognize and destroy cancer cells. Instil Bio aims to transform the treatment landscape for cancer patients by offering personalized and effective therapies that harness the power of the immune system.
Company Address: 3963 Maple Avenue, Suite 350 Dallas 75219 TX
Company Phone Number: 499-3350 Stock Exchange / Ticker: NASDAQ TIL
TIL is expected to report next financial results on March 30, 2024. |
|
|